Reply to: "Comment on 'Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing,' by Dr Rosenthal et al"
1Myriad Genetic Laboratories, Inc, 320 Wakara Way, Salt Lake City, UT 84108.
Abstract
No abstract available in PubMed .
More Related Videos
09:43In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
Published on: August 4, 2011
18.6K
08:23Time-lapse Live Imaging and Quantification of Fast Dendritic Branch Dynamics in Developing Drosophila Neurons
Published on: September 25, 2019
6.7K
